Factor VIII and Platelets Synergistically Accelerate Cleavage of von Willebrand Factor by ADAMTS13 under Fluid Shear Stress

被引:50
作者
Skipwith, Christopher G. [1 ,2 ,3 ]
Cao, Wenjing [2 ,3 ]
Zheng, X. Long [1 ,2 ,3 ]
机构
[1] Childrens Hosp Philadelphia, Biochem & Mol Biophys Grad Program, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
基金
美国国家航空航天局; 美国国家卫生研究院;
关键词
FACTOR-CLEAVING PROTEASE; GLYCOPROTEIN IB; ENDOTHELIAL-CELLS; BINDING; ULTRALARGE; SURFACE; CONFORMATION; DEFICIENCY; MUTATIONS; THROMBIN;
D O I
10.1074/jbc.M110.131227
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies have demonstrated that factor VIII (FVIII) or platelets alone increase cleavage of von Willebrand factor (VWF) by ADAMTS13 under mechanically induced shear stresses. We show in this study that the combination of FVIII and platelets at the physiological concentrations is more effective than either one alone. In the absence of FVIII, lyophilized platelets increase the formation of cleavage product by 2-3-fold. However, in the presence of physiological concentration of FVIII (1 nM), the formation of VWF cleavage product increases dramatically as a function of increasing platelets with the maximal rate enhancement of similar to 8-fold. Conversely, in the presence of a physiological concentration of lyophilized platelets (150 x 10(3)/mu l), the half-maximal concentration of FVIII required to accelerate VWF proteolysis by ADAMTS13 reduces by similar to 10-fold (to similar to 0.3 nM) compared with that in the absence of platelets (similar to 3.0 nM). Further studies using the FVIII derivative that lacks an acidic region (a3), an antiplatelet glycoprotein 1b alpha IgG, and a purified recombinant VWF-A1 domain or glycoprotein 1b alpha-stripped platelets demonstrate that the synergistic rate-enhancing effect of FVIII and platelets depends on their specific binding interactions with VWF. Our findings suggest that FVIII and platelets are cofactors that regulate proteolysis of multimeric VWF by ADAMTS13 under physiological conditions.
引用
收藏
页码:28596 / 28603
页数:8
相关论文
共 48 条
[11]   Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Wassmer, M ;
Sandoz, P ;
Lammle, B .
BLOOD, 1997, 89 (09) :3097-3103
[12]   Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Lämmle, B .
BLOOD, 1998, 91 (08) :2839-2846
[13]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[14]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234
[15]   CHARACTERIZATION OF THE UNIQUE MECHANISM MEDIATING THE SHEAR-DEPENDENT BINDING OF SOLUBLE VON-WILLEBRAND-FACTOR TO PLATELETS [J].
GOTO, S ;
SALOMON, DR ;
IKEDA, Y ;
RUGGERI, ZM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23352-23361
[16]   von Willebrand factor cleaved from endothelial cells by ADAMTS13 remains ultralarge in size [J].
Jin, S. -Y. ;
Skipwith, C. G. ;
Shang, D. ;
Zheng, X. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) :1749-1752
[17]   Responses to aggregating agents after cleavage of GPIb of human platelets by the O-sialoglycoprotein endoprotease from Pasteurella haemolytica -: Potential surrogates for Bernard-Soulier platelets? [J].
Kinlough-Rathbone, RL ;
Perry, DW ;
Rand, ML ;
Packham, MA .
THROMBOSIS RESEARCH, 2000, 99 (02) :165-172
[18]   Mutations and common polymorphisms in ADAMTS13 gene responsiblefor von Willebrand factor-cleaving protease activity [J].
Kokame, K ;
Matsumoto, M ;
Soejima, K ;
Yagi, H ;
Ishizashi, H ;
Funato, M ;
Tamai, H ;
Konno, M ;
Kamide, K ;
Kawano, Y ;
Miyata, T ;
Fujimura, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11902-11907
[19]   Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy [J].
Laje, Pablo ;
Shang, Dezhi ;
Cao, Wenjing ;
Niiya, Masami ;
Endo, Masayuki ;
Radu, Antoneta ;
DeRogatis, Nicole ;
Scheiflinger, Friedrich ;
Zoltick, Philip W. ;
Flake, Alan W. ;
Zheng, X. Long .
BLOOD, 2009, 113 (10) :2172-2180
[20]   Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura [J].
Levy, GG ;
Nichols, WC ;
Lian, EC ;
Foroud, T ;
McClintick, JN ;
McGee, BM ;
Yang, AY ;
Siemieniak, DR ;
Stark, KR ;
Gruppo, R ;
Sarode, R ;
Shurin, SB ;
Chandrasekaran, V ;
Stabler, SP ;
Sabio, H ;
Bouhassira, EE ;
Upshaw, JD ;
Ginsburg, D ;
Tsai, HM .
NATURE, 2001, 413 (6855) :488-494